Common Risk Factors Add to Inherited Thrombophilia to Predict Venous Thromboembolism Risk in Families.
family medical history
risk assessment
single nucleotide polymorphism
thrombophilia
venous thromboembolism
Journal
TH open : companion journal to thrombosis and haemostasis
ISSN: 2512-9465
Titre abrégé: TH Open
Pays: Germany
ID NLM: 101715740
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
20
09
2018
accepted:
21
12
2018
entrez:
29
6
2019
pubmed:
30
6
2019
medline:
30
6
2019
Statut:
epublish
Résumé
The clinical venous thromboembolism (VTE) pattern often shows wide heterogeneity within relatives of a VTE-affected family, although they carry the same thrombophilia defect. It is then mandatory to develop additional tools for assessing VTE risk in families with thrombophilia. This study aims to assess whether common environmental and genetic risk factors for VTE contribute to explain this heterogeneity. A total of 2,214 relatives from 651 families with known inherited thrombophilia were recruited at the referral center for thrombophilia in Marseilles, France, from 1986 to 2013. A thrombophilia screening was systematically performed in all included relatives. According to the severity of the thrombophilia defect, individuals were split into three groups: no familial defect, mild thrombophilia, and severe thrombophilia. In addition, common genetic factors (ABO blood group and 11 polymorphisms selected on the basis of their association with VTE in the general population) were genotyped. Furthermore, body mass index and smoking were collected. VTE incidence was 1.74, 3.64, and 6.40 per 1,000 person-years in individuals with no familial defect, mild thrombophilia, and severe thrombophilia, respectively. Five common risk factors were associated with VTE in this population: obesity, smoking, ABO blood group, and
Identifiants
pubmed: 31249979
doi: 10.1055/s-0039-1677807
pii: 180058
pmc: PMC6524901
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e28-e35Références
Am J Hum Genet. 2000 Dec;67(6):1452-9
pubmed: 11038326
Epidemiology. 2003 May;14(3):328-32
pubmed: 12859034
J Thromb Haemost. 2004 May;2(5):731-6
pubmed: 15099278
Blood. 2005 Dec 15;106(13):4176-83
pubmed: 16144795
J Thromb Haemost. 2007 Apr;5(4):692-9
pubmed: 17367492
Semin Hematol. 2007 Apr;44(2):62-9
pubmed: 17433897
Arch Intern Med. 2009 Mar 23;169(6):610-5
pubmed: 19307525
J Thromb Haemost. 2009 Nov;7(11):1802-8
pubmed: 19583818
J Thromb Haemost. 2011 Feb;9(2):320-4
pubmed: 21040446
Semin Thromb Hemost. 2011 Nov;37(8):903-7
pubmed: 22198855
Blood. 2012 Jul 19;120(3):656-63
pubmed: 22586183
Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):2021-8
pubmed: 22628432
Thromb Haemost. 2013 Mar;109(3):458-63
pubmed: 23348971
PLoS Med. 2013;10(9):e1001515
pubmed: 24068896
J Thromb Haemost. 2014 Feb;12(2):138-146
pubmed: 24735115
Blood. 2014 Sep 25;124(13):2124-30
pubmed: 25049279
J Am Heart Assoc. 2014 Oct 23;3(5):e001060
pubmed: 25341889
J Thromb Haemost. 2015 Feb;13(2):219-27
pubmed: 25472531
Thromb Haemost. 2015 Nov;114(5):910-9
pubmed: 26354877
J Thromb Haemost. 2016 Jul;14(7):1393-403
pubmed: 27121914
Lancet. 2017 Dec 17;388(10063):3060-3073
pubmed: 27375038
Circulation. 2017 Jan 3;135(1):7-16
pubmed: 27831499
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):1-9
pubmed: 27913455
N Engl J Med. 2017 Sep 21;377(12):1177-1187
pubmed: 28930509
Arch Intern Med. 1998 Mar 23;158(6):585-93
pubmed: 9521222